Novocure Limited Quick Ratio (NVCR) starting from the third quarter 2026 to third quarter 2025, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Quick Ratio
• Working Capital
• LT Debt to Equity
• Debt to Equity
• Leverage Ratio
• Tangible Leverage
• Interest Coverage
• Debt Coverage
• Work. Cap. Per Revenue
Novocure Limited  (NASDAQ: NVCR)

Novocure Limited's Quick Ratio

NVCR's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


In the wake of the increase in Current Liabilities in the third quarter 2026, Quick Ratio fell to 0.38 below Novocure Limited average.

Within Medical Equipment & Supplies industry 150 other companies have achieved higher Quick Ratio than Novocure Limited in third quarter 2026. While Quick Ratio total ranking in the third quarter 2026 has deteriorated compared to the prior quarter from 777 to 2513.

Explain Quick Ratio?
How much Cash & cash equivalents NVCR´s has?
What are NVCR´s Current Liabilities?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

NVCR Quick Ratio (Sep 30 2026)
Q3		 (Jun 30 2026)
Q2		 (Mar 31 2026)
Q1		 (Dec 31 2025)
Q4		 (Sep 30 2025)
Q3
Y / Y Current Liabilities Change -60.17 % -66.73 % -80.55 % -81.57 % 4.76 %
Y / Y Cash & cash equivalent Change -90.06 % -89.11 % -53.5 % -53.36 % 7.67 %
Quick Ratio MRQ 0.38 0.45 3.4 3.66 1.52
NVCR's Total Ranking # 2513 # 777 # 392 # 1243 #
Seq. Current Liabilities Change 22.63 % 73.46 % 4.1 % -82.01 % 2.42 %
Seq. Cash & cash equivalent Change 3.48 % -77.02 % -3.5 % -56.68 % 13.38 %



Quick Ratio third quarter 2026 Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 151
Healthcare Sector # 740
Overall Market # 2513


Quick Ratio Statistics
High Average Low
16.4 7.52 0.45
(Mar 31 2021)   (Jun 30 2026)




Financial Statements
Novocure Limited's Current Liabilities $ 271 Millions Visit NVCR's Balance sheet
Novocure Limited's Cash & cash equivalent $ 103 Millions Visit NVCR's Balance sheet
Source of NVCR's Sales Visit NVCR's Sales by Geography


Cumulative Novocure Limited's Quick Ratio

NVCR's Quick Ratio for the trailling 12 Months

NVCR Quick Ratio

 (Sep 30 2026)
12 Months		 (Jun 30 2026)
12 Months		 (Mar 31 2026)
12 Months		 (Dec 31 2025)
12 Months		 (Sep 30 2025)
12 Months
Y / Y Current Liabilities TTM Growth -72.15 % -56.27 % -22.55 % 42.58 % 189.94 %
Y / Y Cash & cash equivalent TTM Growth -71.79 % -46.48 % -25.67 % -11.21 % 3.85 %
Quick Ratio TTM 1.46 1.75 1.77 1.57 1.44
Total Ranking TTM # 3931 # 2932 # 2013 # 2886 #
Seq. Current Liabilities TTM Growth -35.56 % -27.8 % -24.86 % -20.34 % 1.17 %
Seq. Cash & cash equivalent TTM Growth -46.25 % -28.75 % -14.97 % -13.36 % 1.96 %

Quick ratio ranking by company, industry and sector >> Back to NVCR Financial Strength Comparisons >> Go to Compare NVCR Quick Ratio to its Competitors

On the trailing twelve months basis In spite of the year on year decrease in NVCR's Current Liabilities to $270.66 millions, cumulative Quick Ratio to 1.46 below the NVCR average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Medical Equipment & Supplies industry 199 other companies have achieved higher Quick Ratio than Novocure Limited. While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the second quarter 2026 from 2932 to 3931.

Explain Quick Ratio?
How much Cash & cash equivalents NVCR´s has?
What are NVCR´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Medical Equipment & Supplies Industry # 200
Healthcare Sector # 887
Within the Market # 3931


trailing twelve months Quick Ratio Statistics
High Average Low
7.61 4.61 1.26
(Sep 30 2021)   (Jun 30 2025)




Companies with similar Quick Ratio in the quarter ending Sep 30 2026, within Medical Equipment & Supplies Industry Quick RatioSep 30 2026 MRQ Cash & cash equivalentSep 30 2026 MRQ Current Liabilities
Globus Medical Inc   1.02 $ 517.435  Millions$ 507.938  Millions
Envoy Medical Inc   0.98 $ 14.570  Millions$ 14.861  Millions
Integra Lifesciences Holdings Corp  0.95 $ 311.930  Millions$ 329.002  Millions
Strata Critical Medical Inc   0.92 $ 41.641  Millions$ 45.118  Millions
Haemonetics Corporation  0.87 $ 260.712  Millions$ 300.838  Millions
Treace Medical Concepts Inc   0.86 $ 39.798  Millions$ 46.079  Millions
Innovage Holding Corp   0.85 $ 162.993  Millions$ 192.479  Millions
Lifestance Health Group Inc   0.84 $ 218.818  Millions$ 261.129  Millions
Neuronetics Inc   0.82 $ 22.106  Millions$ 26.856  Millions
Orthopediatrics Corp  0.80 $ 44.229  Millions$ 55.632  Millions
Livanova Plc  0.76 $ 563.467  Millions$ 740.193  Millions
West Pharmaceutical Services Inc   0.72 $ 464.100  Millions$ 644.300  Millions
Resmed Inc   0.72 $ 1,010.742  Millions$ 1,406.488  Millions
Electrocore Inc   0.69 $ 7.506  Millions$ 10.866  Millions
Sintx Technologies Inc   0.67 $ 2.005  Millions$ 3.004  Millions
Privia Health Group Inc   0.66 $ 446.283  Millions$ 674.358  Millions
Carlisle Companies Incorporated  0.62 $ 546.700  Millions$ 880.300  Millions
Align Technology inc   0.57 $ 1,144.931  Millions$ 2,002.010  Millions
Angiodynamics Inc   0.57 $ 33.973  Millions$ 59.689  Millions
Baxter International Inc   0.52 $ 1,976.000  Millions$ 3,809.000  Millions
Stryker Corp  0.50 $ 3,271.000  Millions$ 6,500.000  Millions
Msa Safety Inc  0.50 $ 187.248  Millions$ 373.698  Millions
Teleflex Incorporated  0.50 $ 454.065  Millions$ 917.102  Millions
Avita Medical Inc   0.46 $ 10.500  Millions$ 23.037  Millions
Alphatec Holdings Inc   0.44 $ 79.936  Millions$ 180.767  Millions
Steris Plc  0.44 $ 531.100  Millions$ 1,207.800  Millions
Novocure Limited  0.38 $ 102.738  Millions$ 270.659  Millions
Cadre Holdings inc   0.36 $ 63.916  Millions$ 178.051  Millions
U S Physical Therapy Inc  0.35 $ 38.225  Millions$ 109.218  Millions
Tandem Diabetes Care Inc   0.28 $ 72.840  Millions$ 256.075  Millions

Date modified: 2026-10-30T13:18:39+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.